Related references
Note: Only part of the references are listed.Design, synthesis and biological evaluation of homoerythrina alkaloid derivatives bearing a triazole moiety as PARP-1 inhibitors and as potential antitumor drugs
Shuai Li et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis and anticancer activities of novel dual poly(ADP-ribose) polymerase-1/histone deacetylase-1 inhibitors
Yongbin Tian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
PARP and PARG inhibitors in cancer treatment
Dea Slade
GENES & DEVELOPMENT (2020)
Causes of death among cancer patients in the era of cancer survivorship in Korea: Attention to the suicide and cardiovascular mortality
Chang-Mo Oh et al.
CANCER MEDICINE (2020)
Novel allosteric PARP1 inhibitors for the treatment of BRCA-deficient leukemia
Elizabeth Hewlett et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
Synthesis of 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide and 3-oxo-3, 4-dihydrobenzo[b][1,4]oxazine-8-carboxamide derivatives as PARP1 inhibitors
Xuwei Shao et al.
BIOORGANIC CHEMISTRY (2020)
Design and synthesis of novel phthalazinone derivatives as potent poly(ADP-ribose)polymerase 1 inhibitors
Minhang Xin et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors
Sayed K. Ramadan et al.
RSC ADVANCES (2020)
Synthesis and evaluation of an AZD2461 [18F] PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant
Sean W. Reilly et al.
BIOORGANIC CHEMISTRY (2019)
Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold
Ghada F. Elmasry et al.
BIOORGANIC CHEMISTRY (2019)
Discovery of Novel Bromophenol Thiosemicarbazone Hybrids as Potent Selective Inhibitors of Poly(ADP-ribose) Polymerase-1 (PARP-1) for Use in Cancer
Chuanlong Guo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity
Uday Kiran Velagapudi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis and evaluation of phthalazinone thiohydantoin-based derivative as potent PARP-1 inhibitors
Yi Zhong et al.
BIOORGANIC CHEMISTRY (2019)
Discovery of novel functionalized 1,2,4-triazoles as PARP-1 inhibitors in breast cancer: Design, synthesis and antitumor activity evaluation
Ahmed T. A. Boraei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis, biological evaluation and molecular docking of novel molecules to PARP-1 enzyme
Fatih Tok et al.
TURKISH JOURNAL OF CHEMISTRY (2019)
Design, synthesis and evaluation of potent and selective inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14
Jacob Holechek et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Design, synthesis and anticancer activities evaluation of novel 5H-dibenzo[b,e]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units
Xin He et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer
Hadia Almahli et al.
BIOORGANIC CHEMISTRY (2018)
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
Xuxing Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity
Jie Zhou et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
Synthesis of disaccharide nucleoside analogues as potential poly(ADP-ribose) polymerase-1 inhibitors
Meng Zheng et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
A review and update of vertebral fractures due to metastatic tumors of various sites to the spine: Percutaneous vertebroplasty
Mohamad Mansoorinasab et al.
INTERVENTIONAL MEDICINE AND APPLIED SCIENCE (2018)
Design, Synthesis, and Biological Evaluation of Some Cyclohepta[b]Thiophene and Substituted Pentahydrocycloheptathieno[2,3-d]Pyrimidine Derivatives
Elshaymaa I. Elmongy et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2017)
Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy
Zigao Yuan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of 2-substituted 1H-benzo[d]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity
Jie Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
Luyao Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors
Navriti Chadha et al.
MOLECULAR DIVERSITY (2017)
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Novel Benzamide Derivatives: Synthesis and Bioactivity as Potent PARP-1 Inhibitors
Hwani Ryu et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2017)
Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy
Wen-hua Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Discovery of novel quinazoline-2,4(1H,3H)-dione derivatives as potent PARP-2 selective inhibitors
Hailong Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Design and synthesis of potent inhibitors of the mono(ADP-ribosyl) transferase, PARP14
Kristen Upton et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Identification of low micromolar dual inhibitors for aldose reductase (ALR2) and poly (ADP -ribose) polymerase (PARP-1) using structure based design approach
Navriti Chadha et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent
Bing Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel tricyclic poly (ADP-ribose) polymerase-1/2 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis and biological evaluation
Hui Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors
Junwei Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival
T. Jubin et al.
CELL PROLIFERATION (2016)
Design, Synthesis, and Biological Evaluation of Novel PARP-1 Inhibitors Based on a 1H-Thieno[3,4-d]Imidazole-4-Carboxamide Scaffold
Lingxiao Wang et al.
MOLECULES (2016)
Design, synthesis and bioevaluation of 1H-indole4-carboxamide derivatives as potent poly(ADP-ribose) polymerase-1 inhibitors
Zhouling Xie et al.
RSC ADVANCES (2016)
Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer
Leilei Fu et al.
SCIENTIFIC REPORTS (2016)
Benzimidazole derivatives as potential dual inhibitors for PARP-1 and DHODH
Iskandar Abdullah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors
Haiping Yao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis and biological evaluation of isoindoloisoquinolinone, pyroloisoquinolinone and benzoquinazolinone derivatives as poly(ADP-ribose) polymerase-1 inhibitors
Arumugam Suyavaran et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Identification of novel PARP-1 inhibitors: Drug design, synthesis and biological evaluation
Zhouling Xie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Design, synthesis and biological evaluation of pyridazino[3,4,5-de]quinazolin-3(2H)-one as a new class of PARP-1 inhibitors
Jie Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Geoffrey Kim et al.
CLINICAL CANCER RESEARCH (2015)
Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo
Filip Zmuda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis, [18F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography
Dong Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors
Raffaella Cincinelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Synthesis and biological evaluation of substituted 4-(thiophen-2-ylmethyl)-2H-phthalazin-1-ones as potent PARP-1 inhibitors
Ling-xiao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors
Jianyang Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
Julio C. Morales et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2014)
Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor
Beilei Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery and Structure-Activity Relationship of Novel 2,3-Dihydrobenzofuran-7-carboxamide and 2,3-Dihydrobenzofuran-3(2H)-one-7-carboxamide Derivatives as Poly(ADP-ribose)polymerase-1 Inhibitors
Maulik R. Patel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors
Anthony R. Gangloff et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors
Qihua Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
BMN673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
Yuqiao Shen et al.
CLINICAL CANCER RESEARCH (2013)
Design, Synthesis, and Biological Evaluation of a Series of Benzo[de][1,7]naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors
Na Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose) polymerase-1 inhibitors
Shridhar S. Kulkarni et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
PARP inhibitors: its role in treatment of cancer
Alice Chen
Chinese Journal of Cancer (2011)
Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and-2 Mutant Tumors
Philip Jones et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Share Paper
